Purity >80% by SDS-PAGE and Coomassie blue staining. MW (theoretical): 33 kDa. The NLRP1/NALP1 Recombinant Protein Antigen from Novus Biologicals is derived from E. coli. The NLRP1/NALP1 Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.
Size
100 ul
Concentration
n/a
Applications
Antibody Competition
Other Names
CARD7SLEV1, Caspase recruitment domain-containing protein 7, CLR17.1, Death effector filament-forming ced-4-like apoptosis protein, DEFCAPVAMAS1, DKFZp586O1822, KIAA0926DEFCAP-L/S, NACHT, leucine rich repeat and PYD (pyrin domain) containing 1, NACHT, leucine rich repeat and PYD containing 1, NACHT, LRR and PYD containing protein 1, NACHT, LRR and PYD domains-containing protein 1, NACPP1044, NALP1caspase recruitment domain protein 7, NLR family, pyrin domain containing 1, Nucleotide-binding domain and caspase recruitment domain, nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domaincontaining 1